< Back to previous page
Researcher
Maarten Lambrecht
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Department of Oncology (Department)
Member
From1 Oct 2017 → 20 Dec 2018 - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2010 → Today
Projects
1 - 7 of 7
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Implementation of AI-based contouring and treatment planning for daily personalized RT treatments for lung cancerFrom1 Jun 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Self-management of symptom clusters in (ex-) breast, prostate and lung cancer patients treated with radiotherapy: development of a care trajectory.From1 Jan 2022 → 31 Aug 2022Funding: Foundations, funds and other with scientific goal
- Neurocognition-sparing radiotherapy of brain and base of skull tumours: modelling toxicity and probing dose-dependent alterations in the brain using advanced imaging techniques.From18 Nov 2020 → TodayFunding: FWO fellowships
- Exploring strategies to reduce toxicity in the multimodal treatment of esophageal cancerFrom1 Jun 2017 → 31 May 2021Funding: Nonprofit institution or equivalents
- Exploring strategies to reduce toxicity in the multimodal treatment of oesophageal cancerFrom1 Aug 2016 → 9 Nov 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- The role of functional imaging and molecular profiling in image guided highly conformal radiotherapy for head and neck cancer: towards a patient tailored treatment.From1 Aug 2009 → 17 Dec 2013Funding: FWO fellowships
Publications
1 - 10 of 73
- 18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial(2023)
Authors: Maarten Lambrecht
- A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors(2023)
Authors: Hans Wildiers, Gwen Schroyen, Maarten Lambrecht, Sabine Deprez, Charlotte Sleurs
- Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study(2023)
Authors: Maarten Lambrecht
- Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Disseminated Thymoma: A Systematic Literature Review(2023)
Authors: Jan Van Slambrouck, Paul Clement, Maarten Lambrecht, Philippe Nafteux, Dirk Van Raemdonck, Laurens Ceulemans
Pages: 543 - 560 - Neurocognition in adults with intracranial tumors: does location really matter?(2022)
Authors: Charlotte Sleurs, Laurien De Roeck, Stefan Sunaert, Maarten Lambrecht
Pages: 619 - 629 - The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study(2022)
Authors: Gilles Defraene, Maarten Lambrecht
Pages: 127 - 137 - High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer(2022)
Authors: Maarten Lambrecht, Karin Haustermans, Gert De Meerleer
- Low-dose CT allows for accurate proton therapy dose calculation and plan optimization(2022)
Authors: Masoud ElhamiAsl, Gilles Defraene, Maarten Lambrecht, Edmond Sterpin, Johan Nuyts
- ASO Visual Abstract: Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Disseminated Thymoma-A Systematic Literature Review(2022)
Authors: Jan Van Slambrouck, Paul Clement, Maarten Lambrecht, Philippe Nafteux, Dirk Van Raemdonck, Laurens Ceulemans
- Estimates of alpha/beta ratios for individual late urinary toxicity endpoints: analysis of a cohort trial(2022)
Authors: Maarten Lambrecht
Pages: S485 - S488